Federal Precision Medicine Initiative Championed by MSU Alumnus
Earlier this year, President Obama announced his intention to launch the precision medicine initiative in order to bring the nation closer to curing diseases like cancer and diabetes and to provide access to the personalized information needed to keep individuals and families healthier.
|Join us to learn more about the precision medicine initative from…
Senior advisor at the National Human Genome Research Institute of the National Institutes of Health
Mon., Nov. 2 – 2 p.m. at Kellogg Center Auditorium
Precision medicine is an approach to disease treatment and prevention that looks to maximize effectiveness by taking into account individual variability in genes, environment and lifestyle. It also seeks to redefine our understanding of disease onset and progression, treatment response, and health outcomes through the more precise measurement of molecular, environmental and behavioral factors.
To achieve these goals, the program will enroll about 1 million participants that represent the diversity of the nation’s population and will follow their health and clinical outcomes over time.
In an effort to help Michigan State University researchers learn more about the initiative, Vence Bonham, senior advisor at the National Human Genome Research Institute of the National Institutes of Health and MSU alumnus, will be visiting campus in early November.
To learn more, visit the NIH Precision Medicine website.
– Melanie Kauffman